×

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Description
Date : December 2016
Honolulu : Thursday, December 8th 2016 from 04am to 06am (GMT-10)
San Francisco : Thursday, December 8th 2016 from 06am to 08am (GMT-8)
New York : Thursday, December 8th 2016 from 09am to 11am (GMT-5)
Buenos Aires : Thursday, December 8th 2016 from 11am to 01pm (GMT-3)
London / Dublin : Thursday, December 8th 2016 from 02pm to 04pm (GMT)
Paris / Berlin : Thursday, December 8th 2016 from 03pm to 05pm (GMT+1)
Istanbul : Thursday, December 8th 2016 from 04pm to 06pm (GMT+2)
Moscou / Dubaï : Thursday, December 8th 2016 from 06pm to 08pm (GMT+4)
Bangkok : Thursday, December 8th 2016 from 09pm to 11pm (GMT+7)
Shanghai : Thursday, December 8th 2016 from 10pm to 12am (GMT+8)
Tokyo : Thursday, December 8th 2016 from 11pm to 01am (GMT+9)
Sydney : Friday, December 9th 2016 from 12am to 02am (GMT+10)
Wellington : Friday, December 9th 2016 from 02am to 04am (GMT+12)
Last update : 2017-11-13
Language(s) : English

 

In the last twenty years, endovascular technology has revolutionized the management of patients with abdominal aortic aneurysm (AAA) because of its less invasiveness.

Endovascular stent grafting is a newer form of treatment for Abdominal Aortic Aneurysm that is less invasive than open surgery. The technology has evolved from large profile endoprothesis but requires open-surgery to low profile endoprothesis implantable percutaneously (PEVAR).

Furthermore, the development of different type of endoprothesis and extension has allowed the treatment of more complex abdominal aorta aneurysm.
This second websymposium describes the latest low profile endovascular prothesis and its use by our Italian colleagues.

Program (GMT +1) 

16:00 Introduction – Prof. Torsello
16:10 1st case in the box"52 mm asymptomatic AAA treated with incraft Endograft" - Dr. Schwindt
16:30 The Durability and long term data for low profile AAA stent grafts   - Dr. Schwindt
16:40 2nd case in the box"Complex EVAR in tortuous anatomy and exclusion of hypogastric artery aneurysm with the low profile Incraft prothesis" - Dr. Schwindt
17:05 The use of low profile AAA stent graft in our daily practice - Prof. Torsello
17:15 3rd case in the box – Prof. Torsello
17:35 Q&A final discussion and debate - Prof. Torsello, Dr Schwindt
18:00 Take home messages - end of the webinar

Educational objectives

  • Discuss current use of low profile AAA stent grafts
  • Provide platform for discussion of the patients’ outcomes and population treated with low profile AAA stent grafts
  • Demonstrate advanced techniques in the treatment of aortic disease
  • Demonstrate new tools available
  • Provide platform for discussion and mutual learning

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists)
  • Referring physicians of patients with vascular disease


IMPORTANT NOTICE

This webinar is an educational event supported by Cordis Corporation, and is intended for Healthcare Professionals in Europe Middle East and Africa. 
The use of the INCRAFT® AAA Stent-Graft System requires that physicians be specially trained in endovascular abdominal aortic aneurysm repair techniques, including experience with high resolution fluoroscopy and radiation safety. Cordis Corporation will provide training specific to the INCRAFT® AAA Stent-Graft System.
The INCRAFT® System is currently approved for investigational device use only in the U.S. and Japan and is being studied in a global pivotal clinical study in the U.S. and Japan called the INSPIRATION Trial, which completed enrollment in 2013.

While every effort is made to see that no inaccurate or misleading data, opinions, or statements appear in this webinar, Cordis Corporation wish to make it clear that material contained in the webinar represents independent evaluations and opinions of the authors and contributors. As a consequence, Cordis Corporation accepts no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content or the use of any drug or medical device in a way that lies outside its current licensed application in any territory. This presentation may include the demonstration of the use of medical devices; it is not intended to be used as a training guide. The steps demonstrated may not be the complete steps of the procedure. Individual preference and experience, as well as patient needs, may dictate variation in procedure steps. Before using any medical device, including those demonstrated or referenced in this webinar, review all relevant package inserts, with particular attention to the indications, contraindications, warnings and precautions, and steps for use of the device.

All content in these presentations is owned by their authors and is protected by worldwide copyright laws. No modification or further reproduction of the content is permitted. 

Prof. Torsello, Prof. Kellersmann and Dr. Schwindt  are compensated by and presenting on behalf of Cordis.

©2016 Cardinal Health.  All Rights Reserved.
CORDIS and the Cordis LOGO is a trademark of Cordis Corporation.

EU1053  10/16 

Linked playlists (1)
Comments(7)
Join the Discussion
See previous comments (2)
  • gerson U. Great work! What make is your angio machine and table? What is the failure rate of the pre-closure device?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Paulo P. Dears Drs. Giovanni Torsello and Arne Schwindt, Congratulations for the excellent presentiation ! Regards, Paulo Ocke Reis (Brazil,RJ)

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Patricio N. Can you expect a tipe 1 endoleak in this case?

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        • Arne S. Dear Gerson Uanivi, we worked in a Siemens Hybrid OR with a AXIUM ARTIS Machine, The Preclose thechnique has a learning curve, in our experience the success rate of sugeons with 20+ cases is 95%. All the best Arne Schwindt

            Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
            Your browser doesn't have Flash, Silverlight or HTML5 support.


          • Arne S. Dear Patricio Navarro, both patients received a post OR CT, Patient one has a type II EL via the IMA, Patient two has a verry small type II EL via lumbar L5, no type IA or B EL were detected. I wish you a happy 2017 Arne Schwindt

              Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
              Your browser doesn't have Flash, Silverlight or HTML5 support.


            • Elias K. good evening, i was a few days late watching the video.
              For up to 18F puncture sites, would you use one prostar or two perclose devices and why?

              • Arne S. Dear Dr. K.,
                in our setting we use one Prostar device for all large access procedures (EVAR, TEVAR, FEVAR...). The reason is that using one device instead of two is a bit less time consuming. However using two Proglides instead seems to be an alternative. There is one publication showing superiority of Proglide versus Prostar ( if I recall right recently in Eurointervention) for TAVI but you could argue that for cardiologists Priglide is more comfortable because the slipknot is inherited whilst for Prostar it has to be fascilitated by the user. For my taste both strategies are good as long as you got a good training on the device.
                All the best
                Arne Schwindt

              Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
              Your browser doesn't have Flash, Silverlight or HTML5 support.


            Comment with Facebook

            Thursday, February 28th 2019 from 11:30am to 01pm (GMT+2)
            Honolulu : Wednesday, February 27th 2019 from 11:30pm to 01am (GMT-10)
            San Francisco : Thursday, February 28th 2019 from 01:30am to 03am (GMT-8)
            New York : Thursday, February 28th 2019 from 04:30am to 06am (GMT-5)
            Buenos Aires : Thursday, February 28th 2019 from 06:30am to 08am (GMT-3)
            London / Dublin : Thursday, February 28th 2019 from 09:30am to 11am (GMT)
            Paris / Berlin : Thursday, February 28th 2019 from 10:30am to 12pm (GMT+1)
            Istanbul : Thursday, February 28th 2019 from 11:30am to 01pm (GMT+2)
            Moscou / Dubaï : Thursday, February 28th 2019 from 01:30pm to 03pm (GMT+4)
            Bangkok : Thursday, February 28th 2019 from 04:30pm to 06pm (GMT+7)
            Shanghai : Thursday, February 28th 2019 from 05:30pm to 07pm (GMT+8)
            Tokyo : Thursday, February 28th 2019 from 06:30pm to 08pm (GMT+9)
            Sydney : Thursday, February 28th 2019 from 07:30pm to 09pm (GMT+10)
            Wellington : Thursday, February 28th 2019 from 09:30pm to 11pm (GMT+12)

            Introducing innovative solutions for the treatment of visceral arteries in complex BEVAR and FEVAR

            Best clinical practice for achieving perfusion of visceral arteries

            Share
            May 2016
            Honolulu : Wednesday, May 11th 2016 from 04am to 06am (GMT-10)
            San Francisco : Wednesday, May 11th 2016 from 07am to 09am (GMT-7)
            New York : Wednesday, May 11th 2016 from 10am to 12pm (GMT-4)
            Buenos Aires : Wednesday, May 11th 2016 from 11am to 01pm (GMT-3)
            Reykjavik : Wednesday, May 11th 2016 from 02pm to 04pm (GMT)
            London / Dublin : Wednesday, May 11th 2016 from 03pm to 05pm (GMT+1)
            Paris / Berlin : Wednesday, May 11th 2016 from 04pm to 06pm (GMT+2)
            Istanbul : Wednesday, May 11th 2016 from 05pm to 07pm (GMT+3)
            Moscou / Dubaï : Wednesday, May 11th 2016 from 06pm to 08pm (GMT+4)
            Bangkok : Wednesday, May 11th 2016 from 09pm to 11pm (GMT+7)
            Shanghai : Wednesday, May 11th 2016 from 10pm to 12am (GMT+8)
            Tokyo : Wednesday, May 11th 2016 from 11pm to 01am (GMT+9)
            Sydney : Thursday, May 12th 2016 from 01am to 03am (GMT+11)
            Wellington : Thursday, May 12th 2016 from 03am to 05am (GMT+13)

            Percutaneous EndoVascular Aortic Repair with low profile AAA stent grafts

            Share

            Complex EVAR in tortuous anatomy and exclusion of hypogastric artery aneurysm with the low profile I...

            Infrarenal abdominal aneurysm 52 mm, kinking and coiling iliac access isolated right hypogastric art...

            Share
            Scroll Up